Capricorn Fund Managers’s Travere Therapeutics TVTX Stock Holding History

Capricorn Fund Managers’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.3M	Buy	+321,721	New	+$14.3M	1.44%	19

Other funds holding TVTX

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return

Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return

Capricorn Fund Managers's TVTX Position: Q2 2026 in Review

Capricorn Fund Managers opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 321,721 shares worth $18.3M. The stake represents 1.44% of the portfolio and ranks #19 among its holdings.

35 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

Capricorn Fund Managers held 321,721 shares of Travere Therapeutics worth $18.3M as of Q2 2026.
Travere Therapeutics was a new Capricorn Fund Managers position in Q2 2026.
Travere Therapeutics made up 1.44% of Capricorn Fund Managers's portfolio in Q2 2026, its #19 holding.
35 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.